Distinguished in Giant Papillary Conjunctivitis

Carmen J. Vidal

Complejo Hospitalario Universitario De Santiago
Santiago De Compostela, GA, ES 
Distinguished in Giant Papillary Conjunctivitis
Complejo Hospitalario Universitario De Santiago
Santiago De Compostela, GA, ES 
OverviewLocationsClinical Research

Overview

Carmen Vidal practices in Santiago De Compostela, Spain. Ms. Vidal is rated as a Distinguished expert by MediFind in the treatment of Giant Papillary Conjunctivitis. Her top areas of expertise are Fibrocystic Breast Disease, Giant Papillary Conjunctivitis, Anaphylaxis, Colonoscopy, and Endoscopy.

Her clinical research consists of co-authoring 171 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Giant Papillary Conjunctivitis.

Gender
Female

Locations

Complejo Hospitalario Universitario de Santiago
Santiago De Compostela, GA, Spain
Other Locations
Av. Gran Via, 199-203, L'hospitalet De Llobregat, CT 08908, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicentre, Open Label, Phase IIb Clinical Trial to Evaluate Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites Mixes at 200 DPP/ml (DP/MG/14-1 Dermatophagoides Pteronyssinus / Lepidoglyphus Destructor and DP/MG/14-2 Dermatophagoides Pteronyssinus /Blomia Tropicalis) in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
A Multicentre, Open Label, Phase IIb Clinical Trial to Evaluate Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites Mixes at 200 DPP/ml (DP/MG/14-1 Dermatophagoides Pteronyssinus / Lepidoglyphus Destructor and DP/MG/14-2 Dermatophagoides Pteronyssinus /Blomia Tropicalis) in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
Enrollment Status: Completed
Publish Date: August 08, 2018
Intervention Type: Biological
Study Phase: Phase 2

171 Total Publications

SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.
SQ House Dust Mite Sublingual Immunotherapy Tablet in Children With Allergic Asthma: A Randomised Phase III Trial.
Journal: Allergy
Published: June 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vidal's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile